Treatment of primary palmar hyperhidrosis
Not Applicable
Not yet recruiting
- Conditions
- Skin and Connective Tissue Diseases
- Registration Number
- PACTR202006915898923
- Lead Sponsor
- Mansoura university faculty of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
The study include patients with primary palmar hyperhidrosis aged nine years or more with Hyperhidrosis Disease Severity Scale (HDSS) of at least 2 and agree to keep on follow-up.
Exclusion Criteria
Pregnant and lactating women, hypersensitive to any of the active ingredients or have a history of hypersensitivity, known closed angle glaucoma or known prostatic disorders, intestinal obstruction, toxic megacolon, intestinal atony, severe ulcerative colitis, and myasthenia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie oxybutynin's efficacy in primary palmar hyperhidrosis compared to anticholinergic alternatives?
How does the anticholinergic activity of oxybutynin compare to aluminum chloride hexahydrate in sweat suppression for focal hyperhidrosis?
Are there specific biomarkers that predict differential response to anticholinergic therapy versus topical aluminum compounds in primary hyperhidrosis?
What are the long-term adverse event profiles of systemic oxybutynin versus topical aluminum chloride in hyperhidrosis management?
How do combination therapies involving anticholinergics and iontophoresis compare to monotherapy in primary palmar hyperhidrosis treatment?